Research programme: phosphodiesterase 4 inhibitors - Tetra Discovery Partners

Drug Profile

Research programme: phosphodiesterase 4 inhibitors - Tetra Discovery Partners

Alternative Names: PDE4 inhibitors - Tetra Discovery Partners; PDE4 modulators - Tetra Discovery Partners; PDE4B inhibitor; PDE4D inhibitor; Phosphodiesterase 4 modulators - Tetra Discovery Partners

Latest Information Update: 01 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Tetra Discovery Partners
  • Class Small molecules
  • Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Alzheimer's disease; Brain injuries; Schizophrenia

Highest Development Phases

  • Preclinical Cognition disorders
  • Research Brain injuries; Huntington's disease
  • No development reported Depressive disorders; Mild cognitive impairment; Schizophrenia

Most Recent Events

  • 29 Nov 2016 Tetra Discovery Partners receives a grant from National Institute of Mental Health for development in Depressive disorders
  • 16 Jul 2016 No recent reports of development identified for research development in Depressive disorders in USA
  • 16 Jul 2016 No recent reports of development identified for research development in Mild-cognitive-impairment in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top